Your blood type may influence your vulnerability to the winter vomiting virus
In the last few months, schools all over the country have closed because of outbreaks of norovirus. Also known as , norovirus infections cause watery diarrhea, low-grade fever and, most alarming of all, projectile vomiting, which is an extremely effective way of .

Norovirus is very infectious and spreads rapidly through a confined population, such as at a school or on a cruise ship. Although most sufferers recover in 24 to 48 hours, norovirus is a leading cause of childhood illness and, in developing countries, results in about .
Interestingly, not everyone is equally vulnerable to the virus, and whether you get sick or not .
Norovirus is hard to get rid of
, and I got interested in norovirus because, while norovirus symptoms are distressing under any circumstances, my encounter with the virus was particularly inconvenient. During a seven-day rafting trip down the Grand Canyon, the illness passed through the rafters and crew, one by one. Obviously, the wilderness sanitary facilities were not the best to cope with this outbreak. Luckily, everyone, including me, recovered quickly. It turns out that are common.
As debilitating as the illness it causes can be, the norovirus particle is visually beautiful. It is a type of virus known as “non-enveloped” or “naked,” which means that it never acquires the membrane coating typical of other viruses, such as the flu virus. The norovirus surface is a protein coat, called the “capsid.” The capsid protects the norovirus’ genetic material.
The naked capsid coat is one factor that makes norovirus so difficult to control. Viruses with membrane coatings are susceptible to alcohol and detergents, but not so norovirus. temperatures from freezing to 145 degrees Fahrenheit (about the maximum water temperature in a home dishwasher), soap and mild solutions of bleach. Norovirus can persist on human hands for hours and on and is also resistant to alcohol-based hand sanitizers.
To make things worse, only a tiny dose of the virus – – is needed to cause disease. Given that an infected person can excrete many billions of viral particles, it’s very difficult to prevent the virus from spreading.
Susceptibility to norovirus depends on blood type
When norovirus is ingested, it initially infects the cells that line the small intestine. Researchers don’t know exactly how this infection then causes the symptoms of the disease. But a fascinating aspect of norovirus is that, after exposure, .
Your blood type – A, B, AB or O – is dictated by genes that determine which kinds of molecules, called oligosaccharides, are found on the surface of your red blood cells. Oligosaccharides are made from different types of sugars linked together in complex ways.
The same oligosaccharides on red blood cells also appear on the surface of cells that line the small intestine. Norovirus and a few other viruses use these oligosaccharides to grab onto and infect the intestinal cells. It’s the specific structure of these oligosaccharides that determines whether a given strain of virus can attach and invade.
The presence of one oligosaccharide, called the H1-antigen, is required for attachment by many norovirus strains.
People who do not make H1-antigen in their intestinal cells make up 20% of the European-derived population and are .
More sugars can be attached to the H1-antigen to give the A, B or AB blood types. People who can’t make the A and B modifications have the O blood type.
Different strains of norovirus infect different people
Norovirus evolves rapidly. There are currently known to infect humans, and each strain has different variants. Each one has different abilities to bind to the variously shaped sugar molecules on the intestinal cell surface. These sugars are determined by blood type.
If a group of people is exposed to a strain of norovirus, who gets sick will depend on each person’s blood type. But, if the same group of people is exposed to a different strain of norovirus, different people may be resistant or susceptible. In general, those who do not make the H1-antigen and people with B blood type will tend to be resistant, whereas people with A, AB, or O blood types will , but the pattern will depend on the specific strain of norovirus.
This difference in susceptibility has an interesting consequence. When an outbreak occurs, for example, on a cruise ship, roughly a third of the people may escape infection. Because they do not know the underlying reason for their resistance, I think spared people engage in – for example, “I didn’t get sick because I drank a lot of grape juice.” Of course, these mythical evasive techniques will not work if the next outbreak is a strain to which the individual is susceptible.
Immunity to norovirus is short-lived
A norovirus infection provokes a robust immune response that eliminates the virus in a few days. However, the response appears to be short-lived. Most studies have found that immunity guarding against reinfection with the same norovirus strain lasts . Also, infection with one strain of norovirus offers little protection against infection from another. Thus, you can have repeated bouts with norovirus.
The diversity of norovirus strains and the impermanence of the immune response complicates development of an effective vaccine. Currently, clinical trials are testing the effects of of the two most prevalent norovirus strains.
In general, these experimental vaccines produce ; the of the immune response is now . The next phase of clinical trials will test if the vaccines actually prevent or .
This article is republished from under a Creative Commons license. Read the .
Like what you’ve read? Want more? .

Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.

Bacterial enzyme catalyzes body odor compound formation
Researchers identify a skin-resident Staphylococcus hominis dipeptidase involved in creating sulfur-containing secretions. Read more about this recent Journal of Biological Chemistry paper.